A six-week psychotherapy program, tailored specifically for people with neuromyelitis optica spectrum disorder (NMOSD) and delivered via telehealth, helped to ease anxiety and depression in adults with these conditions — with benefits lasting up to three months after treatment. These are the findings of a U.S. pilot clinical trial (NCT05840055) that tested ACT with NMOSD, an […] The post Telehealth offers a new path for improving mental health in NMOSD appeared first on Neuromyelitis News.
